Piper Sandler Lowers PT on Inspire Medical Systems (INSP) to $150 From $233

Inspire Medical Systems, Inc. (NYSE:INSP) is one of the top NYSE stocks with the highest upside potential. Piper Sandler lowered the firm’s price target on Inspire Medical Systems, Inc. (NYSE:INSP) to $150 from $233 on August 5, keeping an Overweight rating on the shares.

A medical professional performing a minimally invasive procedure while using the company’s technology.

The rating update came after the company’s quarterly results, with the firm stating that while Inspire Medical Systems, Inc. (NYSE:INSP) reported better-than-feared fiscal Q2 2025 results, the focus of the EPS call was on the company’s revised FY2025 guidance.

The guidance was considerably lowered to take into account a number of headwinds, a majority of which are associated with the Gen 5 rollout.

The firm added that while it had suspected that it could see a downward revision, it was disappointed by the magnitude of the cut to both the top and bottom-line guide.

Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company that develops and commercializes innovative, minimally invasive solutions for obstructive sleep apnea. The company offers Inspire therapy, which includes implantable components with a pressure-sensing lead, a stimulation lead, and a neurostimulator, operable through a remote control.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.